FindTrial
Sign In

Multicenter cohort construction of neovascular glaucoma

Multicenter cohort construction of neovascular glaucoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300076833
Enrollment
Unknown
Registered
2023-10-20
Start date
2023-02-15
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neovascular glaucoma

Interventions

NVG patient group:N/A

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: (1) IOP higher than 21mmHg; (2) glaucomatous visual field damage or optic nerve damage; (3) New blood vessels were observed on the iris surface

Exclusion criteria

Exclusion criteria: Patients who did not agree to sign an informed consent form.

Design outcomes

Primary

MeasureTime frame
Goldmann intraocular pressure;Naked eye vision test;Best corrected visual acuity;—

Secondary

MeasureTime frame
Front segment photography;Corneal endothelial number;Fundus photograph;Humphrey visual field;Optical coherence tomography;Iris angiography;Retinal angiography;—

Countries

China

Contacts

Public ContactYing Hong

Peking University Third Hospital

drhongying@bjmu.edu.cn+86 136 8153 0093

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026